Young-Soon Na

528 total citations
18 papers, 461 citations indexed

About

Young-Soon Na is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Young-Soon Na has authored 18 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Young-Soon Na's work include Gastric Cancer Management and Outcomes (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Young-Soon Na is often cited by papers focused on Gastric Cancer Management and Outcomes (4 papers), Histone Deacetylase Inhibitors Research (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Young-Soon Na collaborates with scholars based in South Korea, Japan and Singapore. Young-Soon Na's co-authors include Min‐Hee Ryu, Kwang Seok Ahn, Yoon‐Koo Kang, Dongwoo Nam, Won‐Seok Chung, Gautam Sethi, Jong Hyun Lee, Jun‐Hee Lee, Baek‐Yeol Ryoo and Tae Won Kim and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and British Journal of Cancer.

In The Last Decade

Young-Soon Na

18 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Young-Soon Na South Korea 12 271 179 78 70 54 18 461
Ziyan Y. Pessetto United States 12 284 1.0× 132 0.7× 67 0.9× 113 1.6× 56 1.0× 22 521
Jennifer Mahoney United States 7 276 1.0× 256 1.4× 53 0.7× 87 1.2× 80 1.5× 10 550
Jiyuan Yang China 11 294 1.1× 124 0.7× 98 1.3× 188 2.7× 50 0.9× 26 477
Audrey Laroche‐Clary France 16 297 1.1× 245 1.4× 169 2.2× 92 1.3× 40 0.7× 33 604
Michael G. Schlieman United States 8 240 0.9× 279 1.6× 83 1.1× 108 1.5× 40 0.7× 11 498
Ming Ma China 13 289 1.1× 117 0.7× 123 1.6× 140 2.0× 53 1.0× 56 490
Hang Lv China 15 249 0.9× 126 0.7× 132 1.7× 152 2.2× 81 1.5× 34 505
Syed F. Zafar United States 9 132 0.5× 111 0.6× 51 0.7× 65 0.9× 49 0.9× 18 355
Dae Ghon Kim South Korea 13 293 1.1× 81 0.5× 91 1.2× 147 2.1× 31 0.6× 29 589
Xiufeng Liu China 10 111 0.4× 199 1.1× 124 1.6× 69 1.0× 81 1.5× 24 529

Countries citing papers authored by Young-Soon Na

Since Specialization
Citations

This map shows the geographic impact of Young-Soon Na's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Young-Soon Na with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Young-Soon Na more than expected).

Fields of papers citing papers by Young-Soon Na

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Young-Soon Na. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Young-Soon Na. The network helps show where Young-Soon Na may publish in the future.

Co-authorship network of co-authors of Young-Soon Na

This figure shows the co-authorship network connecting the top 25 collaborators of Young-Soon Na. A scholar is included among the top collaborators of Young-Soon Na based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Young-Soon Na. Young-Soon Na is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Kim, Hyung‐Don, et al.. (2020). Clinical implications of neutrophil-to-lymphocyte ratio and MDSC kinetics in gastric cancer patients treated with ramucirumab plus paclitaxel. Chinese Journal of Cancer Research. 32(4). 621–630. 13 indexed citations
2.
Seo, Seyoung, Min‐Hee Ryu, Baek‐Yeol Ryoo, et al.. (2019). Clinical significance of MET gene amplification in metastatic or locally advanced gastric cancer treated with first-line fluoropyrimidine and platinum combination chemotherapy. Chinese Journal of Cancer Research. 31(4). 620–631. 9 indexed citations
3.
4.
5.
Nam, Dongwoo, Jun-Ho Song, Sung‐Moo Kim, et al.. (2014). 8-Hydrocalamenene, Derived from Reynoutria elliptica , Suppresses Constitutive STAT3 Activation, Inhibiting Proliferation and Enhancing Chemosensitization of Human Multiple Myeloma Cells. Journal of Medicinal Food. 17(3). 365–373. 10 indexed citations
6.
Koo, Dong‐Hoe, Min‐Hee Ryu, Baek‐Yeol Ryoo, et al.. (2014). Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumor. Cancer Chemotherapy and Pharmacology. 75(1). 173–182. 32 indexed citations
7.
Lee, Jong Hyun, Dongwoo Nam, Won‐Seok Chung, et al.. (2013). Capillarisin inhibits constitutive and inducible STAT3 activation through induction of SHP-1 and SHP-2 tyrosine phosphatases. Cancer Letters. 345(1). 140–148. 128 indexed citations
8.
Yoo, Changhoon, Min‐Hee Ryu, Young-Soon Na, et al.. (2013). Phase I and pharmacodynamic study of vorinostat combined with capecitabine and cisplatin as first-line chemotherapy in advanced gastric cancer. Investigational New Drugs. 32(2). 271–278. 22 indexed citations
9.
Hong, Seungwoo, Dong‐Hoon Jin, Young-Soon Na, et al.. (2012). Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF). Journal of Biological Chemistry. 287(28). 24017–24025. 45 indexed citations
10.
11.
Jin, Dong‐Hoon, Seungwoo Hong, Dok Hyun Yoon, et al.. (2011). Abstract 2153: P34SEI-1 inhibits ROS-induced cell death through suppression of ASK1. Cancer Research. 71(8_Supplement). 2153–2153. 1 indexed citations
12.
Na, Young-Soon, Kyung‐Ah Jung, Soo Jin Yang, et al.. (2011). Abstract 2539: Antitumor effects of oral paclitaxel DHP107 on gastric cancer xenografts. Cancer Research. 71(8_Supplement). 2539–2539. 1 indexed citations
13.
Na, Young-Soon, Kyung‐Ah Jung, Yong Sang Hong, et al.. (2010). The histone deacetylase inhibitor PXD101 increases the efficacy of irinotecan in in vitro and in vivo colon cancer models. Cancer Chemotherapy and Pharmacology. 68(2). 389–398. 28 indexed citations
14.
Kim, Sung‐Moo, Kyung‐Ran Park, Hyeung-Jin Jang, et al.. (2010). Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway. Cancer Letters. 301(1). 29–37. 28 indexed citations
15.
Cho, Dong‐Hyung, Yoon Kyung Jo, Seon Ae Roh, et al.. (2010). Upregulation of SPRR3 Promotes Colorectal Tumorigenesis. Molecular Medicine. 16(7-8). 271–277. 32 indexed citations
16.
Sohn, Byeong Seok, Tae Won Kim, Jae‐Lyun Lee, et al.. (2009). The Role of <i>KRAS</i> Mutations in Predicting the Efficacy of Cetuximab-Plus-Irinotecan Therapy in Irinotecan-Refractory Korean Metastatic Colorectal Cancer Patients. Oncology. 77(3-4). 224–230. 23 indexed citations
17.
Lee, Sun-Hee, et al.. (2004). Effect of Drinking and Smoking on Skin Health and Make-up. Korean Journal of Human Ecology. 13(2). 263–269. 2 indexed citations
18.
Na, Young-Soon, Keejung Yoon, Byeong‐Sun Choi, et al.. (2004). Nef from a primary isolate of human immunodeficiency virus type 1 lacking the EE155 region shows decreased ability to down-regulate CD4. Journal of General Virology. 85(6). 1451–1461. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ziyan Y. Pessetto Breakdown of academic impact, for papers by Jennifer Mahoney Breakdown of academic impact, for papers by Jiyuan Yang Breakdown of academic impact, for papers by Audrey Laroche‐Clary Breakdown of academic impact, for papers by Michael G. Schlieman Breakdown of academic impact, for papers by Ming Ma Breakdown of academic impact, for papers by Hang Lv Breakdown of academic impact, for papers by Syed F. Zafar Breakdown of academic impact, for papers by Dae Ghon Kim Breakdown of academic impact, for papers by Xiufeng Liu
Rankless by CCL
2026